Tampa General Hospital | Aetna Better Health of Florida Donates $65,000 to Support New Community Garden and Food Pharmacy in East Tampa

Tampa General Hospital

Tampa General Hospital (TGH) has received a $65,000 donation from Aetna Better Health of Florida, part of Aetna® and the CVS Health® family, to support the new TampaWell Community Garden and Food Pharmacy.

Helps Community

The community hub, built on the concept that “food is medicine,” will enable patients at the TGH Family Care Center Healthpark greater access to nutritious foods and the opportunity to learn how to grow healthy produce in a sustainable way.”

TampaWell, activated by Tampa General Hospital in partnership with the City of Tampa, is a revolutionary health and wellness initiative focused on preventative health to reduce chronic disease and repeated hospitalizations, while supporting the city’s most at-risk residents by addressing underlying social factors that impact health.

“Tampa General has done an excellent job at finding new and creative ways to care for the health of their community, so it was an easy decision to partner with them,” said Aetna Better Health of Florida CEO Jennifer Sweet. “We are thankful for their efforts in pushing forward the idea that food is medicine through this garden, and we look forward to seeing the many ways it serves the people of Tampa.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.